Group without ovarian metastasis Group with ovarian metastasis p
    N (%) N (%)  
Family history of tumor No 669 (87.57) 20 (86.96) 0.931
  Yes 95 (12.43) 3 (13.04)  
Gross type Localized 380 (73.22) 9 (64.29) 0.458
  Diffuse 139 (26.78) 5 (35.71)  
Depth of muscular invasion No 179 (25.98) 2 (9.09) 0.01
  <1/2 350 (50.80) 9 (40.91)  
  ≥1/2 160 (23.22) 11 (50)  
Cytology of ascites Negative 330 (89.67) 5 (55.56) 0.001
  Positive 38 (10.33) 4 (44.44)  
Pathological type Endometrioid 679 (88.99) 18 (88.68) 0.11
  Special types* 84 (11.01) 5 (21.74)  
Grade of cell differentiation G1 252 (37.11) 4 (19.05) 0.028
  G2 313 (46.10) 9 (42.86)  
  G3 114 (16.79) 8 (38.10)  
Cervical metastasis No 700 (91.62) 15 (65.22) 0
  Yes 64 (8.38) 8 (34.78)  
Parametrial metastasis No 739 (96.73) 19 (82.61) 0
  Yes 25 (3.27) 4 (17.39)  
Vaginal metastasis No 760 (99.48) 22 (95.65) 0.023
  Yes 4 (0.52) 1 (4.35)  
Oviduct metastasis No 746 (97.64) 20 (86.96) 0.002
  Yes 18 (2.36) 3 (13.04)  
Ligament metastasis No 753 (98.56) 22 (95.65) 0.262
  Yes 11 (1.44) 1 (4.35)  
Vascular carcinoma embolism No 733 (95.94) 21 (91.3) 0.274
  Yes 31 (4.06) 2 (8.7)  
Lymphatic metastasis No 750 (98.17) 20 (86.96) 0
  Yes 14 (1.83) 3 (13.04)  
*Special pathological types include serous papillary adenocarcinoma, clear cell carcinoma and adenosquamous carcinoma
Table 2: Comparative clinicopathological features of endometrial carcinoma patients with and without ovian metastasis.
Goto home»